Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Change in Accured Expenses (2020 - 2025)

Cellebrite DI's Change in Accured Expenses history spans 6 years, with the latest figure at $6.8 million for Q4 2025.

  • Quarterly Change in Accured Expenses fell 41.9% to $6.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $24.0 million through Dec 2025, up 36.48% year-over-year, with the annual reading at $4.2 million for FY2025, 75.84% down from the prior year.
  • Change in Accured Expenses came in at $6.8 million for Q4 2025, down from $17.6 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $17.6 million in Q2 2025 to a low of -$12.2 million in Q1 2025.
  • The 5-year median for Change in Accured Expenses is $2.4 million (2021), against an average of $1.4 million.
  • Year-over-year, Change in Accured Expenses tumbled 184.84% in 2022 and then skyrocketed 809.28% in 2024.
  • Cellebrite DI's Change in Accured Expenses stood at $2.4 million in 2021, then crashed by 184.84% to -$2.1 million in 2022, then skyrocketed by 370.44% to $5.6 million in 2023, then skyrocketed by 110.41% to $11.7 million in 2024, then tumbled by 41.9% to $6.8 million in 2025.
  • Per Business Quant, the three most recent readings for CLBT's Change in Accured Expenses are $6.8 million (Q4 2025), $17.6 million (Q2 2025), and -$12.2 million (Q1 2025).